Can MSCs Treat Patients with COVID-19?
Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel coronavirus (COVID-19) are underway. As of this writing, there are 66 clinical trials ... More
Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel coronavirus (COVID-19) are underway. As of this writing, there are 66 clinical trials ... More
Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More
The use of human mesenchymal stem/stromal cells (hMSCs) has evolved since its discovery in the early 1960s. Continuous learning about hMSCs has shifted the paradigm of theses cells. While originally ... More
Originally Authored February 15, 2014. Updated by Iain Farrance, PhD and Jon Carson, PhD February 5, 2020. What’s in a Name? MSC is the common acronym used to describe Mesenchymal ... More
The seemingly endless complex battle injuries as a result of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF) and Operation New Dawn (OND), and from other unnamed contingency operations worldwide has consumed the ... More
RoosterBio Quality Excellence: we nurture a hard-working innovative culture where quality begins at inception RoosterBio’s mission is to Fuel the Rapid Commercialization of Scalable Regenerative Cures. We contribute to this ... More
Scalable Manufacturing Solution Needed Historically, pre-clinical studies and clinical trials have predominantly used hMSCs derived from bone marrow and adipose tissue sources. However, over the last 10 to 15 years, ... More
Answered by: Amy Permenter, Technical Support Specialist and Tom Rogers, Director, Global Customer Support 1. Do you have a sales representative in my state or country? Yes! RoosterBio has four ... More
Scalability of EV Manufacturing is a Major Challenge Previously, we discussed the emergence of MSC extracellular vesicles (EVs) as clinical therapies. However, a critical barrier in the development of MSC-EVs as a ... More
MSC-EVs Emerge as a Cell-Free Therapy Extracellular vesicle (EV) interest continues to increase as more evidence emerges about the ability of these lipid-bilayer membrane vesicles to elicit specific responses from ... More